Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:13 PM
Ignite Modification Date:
2025-12-25 @ 12:24 PM
NCT ID:
NCT02730195
Group ID:
EG000
Title:
Pioglitazone & TKI Therapy
Description:
Patients receive pioglitazone PO QD on days 1-28. Patients also start or continue the same tyrosine kinase inhibitor (TKI) therapy at the pre-discontinuation doses. Courses repeat every 28 days for 6 months in the absence of disease progression or unacceptable toxicity.
Pioglitazone: Given PO
Tyrosine Kinase Inhibitor (TKI): Given TKI therapy
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
9
Other Number Affected:
7
Other Number At Risk:
9
Study:
NCT02730195
Results Section:
NCT02730195
Adverse Events Module:
NCT02730195